Introduction
============

Polymyxins, including polymyxin B and E (colistins), are generally regarded as the last-resort therapy for infections caused by multidrug resistant (MDR) Gram-negative bacilli, especially carbapenem-resistant Enterobacteriaceae.[@b1-idr-12-105],[@b2-idr-12-105] In recent years, polymyxin resistance has gained wide attention in the field of global medical research due to the increasing reports of polymyxin-resistant bacteria. In late 2015, Chinese researchers reported the first plasmid-mediated colistin resistance gene, *mcr-1*,[@b3-idr-12-105] and since then, it has been reported in other continents as well, including Asia, Europe, America, Africa, and Australia,[@b4-idr-12-105] as well as in several provinces (Zhejiang, Sichuan, Beijing, Guangdong, etc) in China.[@b5-idr-12-105]--[@b9-idr-12-105] The discovery of *mcr-1* gene makes it possible for the horizontal transmission of polymyxin resistance in Enterobacteriaceae, which may in turn lead to a rapid increase in polymyxin resistance. So far, *mcr-1* gene has been found only in Enterobacteriaceae, such as *Escherichia coli*, *Klebsiella pneumoniae*, *Salmonella* spp., *Enterobacter* spp., *Kluyvera ascorbata*, *Raoultella ornithinolytica*, *Citrobacter braakii*, etc.[@b4-idr-12-105],[@b6-idr-12-105],[@b10-idr-12-105],[@b11-idr-12-105]

Studies focusing on the *mcr-1* gene-carrying *E. coli* and *K. pneumonia* strains are common, while the studies on prevalence and molecular characteristics of the *mcr-1* gene in *Salmonella* spp. are still lacking. *Salmonella typhimurium* is an important zoonotic pathogen that usually causes foodborne diseases, and humans, especially infants, are highly susceptible to this infection.[@b12-idr-12-105] Furthermore, the occurrence of MDR isolates of *S. typhimurium* have become common now and have had great impact on the effectiveness of current strategies to prevent and control foodborne diseases.[@b13-idr-12-105] This study aims to analyze the prevalence and molecular characteristics of *mcr-1* gene in *S. typhimurium strains* isolated from Quzhou People's Hospital and provide a basis for the prevention and control of polymyxin resistance in the hospital strains of *S. typhimurium*.

Materials and methods
=====================

Bacterial isolates
------------------

A total of 62 *S. typhimurium* isolates were collected from Quzhou People's Hospital from 2007 to 2016. All the strains were isolated from patients who visited the hospital during the period. Isolates were identified using the automated Vitek 2 system (BioMérieux, Marcy l'Etoile, France).

Screening for *mcr-1* gene
--------------------------

All the isolates were screened for the presence of *mcr-1* gene by PCR with primers mcr-1-F (5′-GCTCGGTCAGTC-CGTTTG-3′) and mcr-1-R (5′-GAATGCGGTGCG-GTCTTT-3′), and positive amplicons were subsequently sequenced. All the sequences were further analyzed on the BLAST server (<http://blast.ncbi.nlm.nih.gov/>).

Antimicrobial susceptibility testing
------------------------------------

Minimum inhibitory concentrations (MICs) of colistin and other ten antimicrobial agents (including levofloxacin, ciprofloxacin, cefotaxime, cefepime, cefoperazone/sulbactam, imipenem, meropenem, amikacin, tigecycline, and aztreonam) were determined for the *mcr-1*-positive isolates by the broth microdilution method, while the MICs of fosfomycin and sulfamethoxazole/trimethoprim were evaluated by the agar dilution method according to the guidelines of Clinical and Laboratory Standards Institute (CLSI). The results were interpreted in accordance with the CLSI and European Committee on Antimicrobial Susceptibility Testing (for colistin, tigecycline, and fosfomycin) breakpoints (<http://www.eucast>. org/clinical_breakpoints).

Southern blot analysis
----------------------

To determine the plasmid location of the *mcr-1* gene, genomic DNA digested with S1 nuclease (TaKaRa, Tokyo, Japan) was electrophoresed on a CHEF-mapper XA pulsed-field gel electrophoresis system (Bio-Rad Laboratories Inc., Hercules, CA, USA) for 22 hours at 14°C with run conditions of 6 V/cm and pulse times from 2.16 seconds to 63.8 seconds. The DNA fragments were transferred to a positively charged nylon membrane (EMD Millipore, Billerica, MA, USA) and then hybridized with a digoxigenin-labeled *mcr-1*-specific probe. The fragments were then detected using a NBT/BCIP color detection kit (Hoffman-La Roche Ltd., Basel, Switzerland).

Whole genome sequencing (WGS)
-----------------------------

The total genomes of the *mcr-1*-positive isolates were extracted and then sequenced on an Illumina-Hiseq™ 2000 sequencing system (Illumina Inc, San Diego, CA, USA) using a paired-end 2×100 bp protocol. Sequence reads were assembled using CLC Genomics Workbench software package (CLC Bio 8.0, Aarhus, Denmark). The multi-locus sequence type (MLST) and other resistant genes were analyzed on the website of Center of Genomics Epidemiology (<http://www.genomicepidemiology.org/>). Gene prediction and annotation were performed using RAST (<http://rast.nmpdr.org/>). Sequence comparison was performed using BLAST (<http://blast.ncbi.nlm.nih.gov>), and physical maps were generated by using Easyfig.[@b14-idr-12-105]

Ethics approval
===============

The clinical isolates were part of the routine hospital laboratory procedure. The Ethics Committee of the Quzhou People's Hospital approved this study as it mainly focused on bacteria, and not the patients.

Results
=======

Epidemiology data and characteristics of *mcr-1*-positive isolates
------------------------------------------------------------------

A total of three *mcr-1*-positive isolates of *S. typhimurium* were identified (16--541, 16--573, and 16--623), with the prevalence rate of 4.8% (3/62). All the three strains were isolated from feces of patients with infectious diarrhea diseases in 2016. Two patients were infants and the other was 15 years old (male =1, female =2). No underlying diseases were found in all the three patients, and all of them were eventually cured ([Table 1](#t1-idr-12-105){ref-type="table"}).

Antimicrobial susceptibility of *mcr-1*-positive isolates
---------------------------------------------------------

All the three *mcr-1*-positive *S. typhimurium* strains were resistant to colistin, with the MIC of 8 µg/mL. Moreover, they were all resistant to the third/fourth-generation cephalosporins (cefotaxime and cefepime) and sulfamethoxazole/trimethoprim, while imipenem, meropenem, amikacin, tigecycline, and fosfomycin showed great activity against these *mcr-1*-positive isolates ([Table 2](#t2-idr-12-105){ref-type="table"}).

*mcr-1* gene locations
----------------------

S1-nuclease digestion and Southern blot analysis indicated that all three *mcr-1* genes were located on plasmids. *mcr-1* genes of isolates 16--541 and 16--623 were located on the same-size plasmids of \~310.1 kb, while the one of isolate 16--573 was located onã60 kb plasmid ([Figure 1](#f1-idr-12-105){ref-type="fig"}).

WGS analysis
------------

The whole genomes of the three *S. typhimurium* strains were sequenced and analyzed.

Other mechanisms associated with antimicrobial resistance were analyzed by using ResFinder. In addition to *mcr-1*, all the three isolates carried a variety of resistance genes to different antibiotics, including aminoglycosides, β-lactams, fluoroquinolones, sulfonamides, tetracyclines, and trimethoprim. In addition, isolate 16--573 carried *fosA3* gene, which induced fosfomycin resistance, while isolates 16--541 and 16--623 carried *ARR-3* gene, which induced rifampicin resistance ([Table 3](#t3-idr-12-105){ref-type="table"}).

Genetic environment of *mcr-1* gene
-----------------------------------

One of the three *mcr-1*-carrying plasmids (16-573) was greatly similar to pEc20COE13 (accession number: KY012274), which belonged to plasmid type IncI2 ([Figure 2A](#f2-idr-12-105){ref-type="fig"}). Although the *mcr-1* gene was found to be inserted at different locations of the plasmid, the *mcr-1* genes located on the contigs of isolates 16-541 and 16-623 were partly similar to the *mcr-1*-positive plasmid p803-DB-mcr (accession number: KY012274), which belonged to plasmid type IncHI2 ([Figure 2B](#f2-idr-12-105){ref-type="fig"}). No IS*Apl*1 elements were identified at the upstream or downstream of *mcr-1* gene.

Discussion
==========

Since the first report of *mcr-1* gene, it has been widely reported all over the world, and can be isolated from animals, food, environment, and humans (patients and healthy people). Apart from the common strains like *E. coli* and *K. pneumonia, mcr-1* gene has also been reported from *Enterobacter aerogenes* and *Enterobacter cloaceae*.[@b15-idr-12-105] *Salmonella* spp., especially *S. typhimurium*, is one of the main hosts of *mcr-1* gene. Although many countries, such as Britain, Italy, the Netherlands, and Portugal, have reported *mcr-1*-carrying *S. typhimurium* isolates, most of them were of animal origin.[@b16-idr-12-105]--[@b19-idr-12-105]

This study analyzed the prevalence and molecular characteristics of *mcr-1* gene in *S. typhimurium* isolates from 2007 to 2016 retrospectively, which were preserved in the laboratory of Quzhou People's Hospital. The results showed that the detection rate of *mcr-1* gene was 4.8%, which was slightly higher than that reported previously (0.06%--1.55%).[@b16-idr-12-105],[@b20-idr-12-105] It is observed that *mcr-1*-positive *S. typhimurium* were not detected until 2016. Furthermore, all the *mcr-1* genes were located on plasmids. One of the three *mcr-1*-carrying plasmids belonged to plasmid type IncI2, and the other two belonged to IncHI2, which was the same as the recently reported *mcr-1*-horbored plasmid of ST34 *S. typhimurium* isolated from pigs in China.[@b21-idr-12-105] All these results suggest that *mcr-1* gene may play an important role in polymyxin resistance of clinically isolated *S. typhimurium* strains and lead to the rapid increase of polymyxin resistance in these bacteria.

*S. typhimurium* is a common clinical pathogenic serotype of *Salmonella* spp. In recent years, there has been a rapid increase in the incidence of antimicrobial resistance among the *Salmonella* spp., which can be attributed to the irrational use of antibiotics in clinics as well as the randomly discharged stools of poultry which can contain the residues of antibiotics.[@b22-idr-12-105] According to the previously reported study, *mcr-1*-positive isolates usually remain susceptible to many other antibiotics.[@b23-idr-12-105] In this study, *mcr-1*-positive strains were resistant to colistin as well as to third/fourth-generation cephalosporins and sulfamethoxazole/trimethoprim. WGS analysis showed that these isolates were all CTX-M-14-type extended-spectrum β-lactamase producing strains and carried sulfonamide and trimethoprim resistance genes, which were in accordance to the resistant phenotype. The MIC of fosfomycin of isolate 16--573 was 64 µg/mL, which was far higher than the MIC of other two isolates (0.25 µg/mL). It was due to the co-expression of *fosA3* in isolate 16--573. In addition, although the isolate also carried quinolone-resistance genes *oqxA* and *oqxB*, it was susceptible to both levofloxacin and ciprofloxacin, which might be due to the non-expression of the two genes.

In China, the most common ST of *S. typhimurium*, especially MDR *S. typhimurium*, is ST34,[@b13-idr-12-105] which is also prevalent in Europe.[@b24-idr-12-105] In this study, all the three *S. typhimurium* isolates belonged to ST34. At the same time, most of the *S. typhimurium* strains carrying *mcr-1* gene were isolated from animals and belonged to ST34,[@b21-idr-12-105],[@b25-idr-12-105] which suggested that ST34 was closely related to antimicrobial resistance and the spread of this clone would pose a great threat to the prevention and control of clinical *S. typhimurium* infections.

Conclusion
==========

In conclusion, colistin-resistant *mcr-1*-positive *S. typhimurium* strains have emerged in Quzhou People's Hospital and belong to the most common sequence type ST34, which is associated with MDR *S. typhimurium*. It is necessary to strengthen the surveillance of polymyxin resistance rate in our hospital to prevent the spread of resistant bacteria.
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![S1-digested plasmid DNA and Southern blot hybridization with *mcr-1* gene of *Salmonella typhimurium* isolates\
**Notes:** The red arrows indicate positive signals via southern blot hybridization with the mcr-1 probes.](idr-12-105Fig1){#f1-idr-12-105}

![Genetic structures of two representative types of plasmids carrying *mcr-1 gene*.\
**Notes:** (**A**) Comparison of *mcr-1*-located contig of isolate 16--573 and pEc_20COE13. (**B**) Comparison of *mcr-1*-located contigs of isolates 16--541 and 16--623 and p803-DB-mcr. The red arrows represent the *mcr-1* gene.](idr-12-105Fig2){#f2-idr-12-105}

###### 

Characteristics of *mcr-1*-positive isolates

  Isolates   Age         Sex      Living place   Underlying disease   Outcome   Department                    Samples   Isolated date
  ---------- ----------- -------- -------------- -------------------- --------- ----------------------------- --------- ---------------
  16--541    15 years    Female   Village        None                 Cured     Gastroenterology department   Feces     8/27/2016
  16--573    8 months    Female   City           None                 Cured     Pediatric department          Feces     9/20/2016
  16--623    10 months   Male     Village        None                 Cured     Pediatric department          Feces     11/2/2016

###### 

MICs of *mcr-1*-positive *Salmonella typhimurium* isolates to colistin and other antibiotics (μg/mL)

  Antibiotics                     16--541      16--573      16--623
  ------------------------------- ------------ ------------ ------------
                                                            
  Colistin                        8 (R)        8 (R)        8 (R)
  Levofloxacin                    4 (I)        0.25 (S)     4 (I)
  Ciprofloxacin                   8 (R)        0.125 (S)    8 (R)
  Cefotaxime                      \>256 (R)    \>256 (R)    \>256 (R)
  Cefepime                        128 (R)      64 (R)       128 (R)
  Cefoperazone/sulbactam          32 (I)       16 (S)       32 (I)
  Imipenem                        0.5 (S)      0.5 (S)      1 (S)
  Meropenem                       0.0625 (S)   0.0625 (S)   0.0625 (S)
  Amikacin                        8 (S)        4 (S)        16 (S)
  Tigecycline                     1 (S)        0.5 (S)      1 (S)
  Fosfomycin                      0.25 (S)     64 (R)       0.25 (S)
  Sulfamethoxazole/trimethoprim   \>32 (R)     \>32 (R)     \>32 (R)
  Aztreonam                       8 (I)        4 (S)        16 (R)

**Abbreviations:** MIC, minimum inhibitory concentration; I, intermediate; R, resistant; S, susceptible.

###### 

Other resistant genes of *mcr-1*-positive *Salmonella typhimurium isolates*

  Isolates/resistant genes   Aminoglycoside                                                                               β-Lactam                                       Fluoroquinolone                        Fosfomycin   Rifampicin   Sulfonamide          Tetracyclines      Trimethoprim
  -------------------------- -------------------------------------------------------------------------------------------- ---------------------------------------------- -------------------------------------- ------------ ------------ -------------------- ------------------ --------------
                                                                                                                                                                                                                                                                                  
  16--541                    *aph(3*′*)-Ia/Ib, aadA1/A2, aac(6*′*)Ib-cr, aph(6)- Id, aph(4)-Ia, aac(3)-Iva*               *bla*~TEM-1B~, *bla*~CTX-M-14~, *bla*~OXA-1~   *oqxA, oqxB, qnrS2, aac(6*′*)-Ib-cr*   None         *ARR-3*      *sul1, sul2, sul3*   *tet(A), tet(B*)   *dfrA12*
  16--573                    *aph(3*′*)-Ia, aadA1/A2, aph(4)-Ia, aac(3)-Iva*                                              *bla*~CTX-M-14~                                *oqxA, oqxB*                           *fosA3*      None         *sul1, sul2, sul3*   *tet(B*)           *dfrA12*
  16--623                    *aph(3*′*)-Ia, aadA1/A2, aac(6*′*)Ib-cr, aph(4)- Ia, aac(3)-Iva, aph(3*′′*)-Ib, aph(6)-Id*   *bla*~TEM-1B~, *bla*~CTX-M-14~, *bla*~OXA-1~   *oqxA, oqxB, qnrS2, aac(6*′*)-Ib-cr*   None         *ARR-3*      *sul1, sul2, sul3*   *tet(B*)           *dfrA12*
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